The effect of choice of platinum on survival and factors affecting survival in metastatic small cell lung cancer: A Single Center Experience

The effect of choice of platinum on survival and factors affecting survival in metastatic small cell lung cancer: A Single Center Experience

INTRODUCTION: In this retrospective study, we aimed to analyze the effect of choice of platinum chemotherapy (carboplatin vs. cisplatin) on survival in patients with small cell lung cancer(SCLC) and to identify the factors affecting survival. METHODS: A total of 87 metastatic SCLC patients with avai...

Full description

Bibliographic Details
Main Authors:	Ayşegül Sakin, mehmet naci aldemir, murat alay
Format:	Article
Language:	English
Published:	Van Yuzuncu Yil University, School of Medicine 2021-01-01
Series:	Van Tıp Dergisi
Subjects:	small cell lung cancer prognostic factors cisplatin carboplatin survival
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-46244

Similar Items

Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab
by: Reyes Bernabé, et al.
Published: (2024-01-01)

Reducing renal function assessment prior to platinum-based chemotherapy: a real-world evaluation
by: Suzanne van der Gaag, et al.
Published: (2024-04-01)

Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds
by: Loredana G. Marcu
Published: (2022-02-01)

Switching cisplatin to carboplatin in chemotherapy for metastatic penile cancer in a patient intolerant to cisplatin
by: Keita Sekine, et al.
Published: (2024-11-01)

Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors
by: Alberto Romano, et al.
Published: (2023-01-01)

Pharmacotherapy of small cell lung cancer: Current state-of-the-art
by: Tatyana A. Berezhnova, et al.
Published: (2023-03-01)

Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines
by: Brittany P. Rickard, et al.
Published: (2023-12-01)

Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario
by: Francesco Trevisani, et al.
Published: (2022-04-01)

Adenosine Overcomes Triple-Negative Breast Cancer Resistance to Platinum-Derived Chemotherapeutic Drugs
by: Ana Cerquido, et al.
Published: (2022-11-01)

Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy
by: Macus Tien Kuo, et al.
Published: (2021-06-01)

Dynamic assessment of long-term survival in survivors with stage III non-small cell lung cancer: a novel conditional survival model with a web-based calculator
by: Xiangdi Meng, et al.
Published: (2025-01-01)

DISSEMINATED NON SMALL-CELL LUNG CANCER: POSSIBILITIES OF DRUG THERAPY IN THE FIRST DECADE OF THE XXI CENTURY
by: A. M. Garin, et al.
Published: (2014-07-01)

The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer
by: Junhwan Kim, et al.
Published: (2025-01-01)

Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy
by: Jiafeng Liu, et al.
Published: (2023-12-01)

Synergistic Antitumor Interaction of Risedronate Sodium and Standard Anticancer Agents in Canine (D-17) and Human Osteosarcoma (U-2 OS) Cell Lines
by: Dominik Poradowski, et al.
Published: (2022-03-01)

Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma
by: Guanyu Huang, et al.
Published: (2024-01-01)

Comparison of Chemotherapy Regiments between Cisplatin Etoposide and Cisplatin-Docetaxel on 2-Year and Progression-Free Survival in Late-Stage Non-Small Cell Lung Cancer Patients
by: Salman Paris Harahap, et al.
Published: (2016-06-01)

Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?
by: Aren Ebrahimi, et al.
Published: (2023-05-01)

The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer
by: A. Sakin, et al.
Published: (2021-01-01)

How Morphology Shapes Survival in Invasive Squamous Cell Carcinoma of the Lung
by: Angela-Ștefania Marghescu, et al.
Published: (2024-10-01)

A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non‐small cell lung cancer (LOGIK1902)
by: Taishi Harada, et al.
Published: (2024-10-01)

Comparing the associations between host and tumor factors with survival outcomes with anti‐PD‐1 immunotherapy in metastatic melanoma
by: Kim Koczka, et al.
Published: (2023-02-01)

A Potentially Less Nephrotoxicity of Carboplatin Over Cisplatin as Radiosensitizer in Head-neck Cancer
by: Mahfujul Ahmed Riad
Published: (2022-08-01)

Analysis of survival rates and evaluation of prognostic factors in patients with lung metastases from renal cell carcinoma
by: D. V. Semyonov, et al.
Published: (2024-05-01)

Assessing lung cancer progression and survival with infrared spectroscopy of blood serum
by: Kosmas V. Kepesidis, et al.
Published: (2025-02-01)

A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma
by: Lei Liu, et al.
Published: (2021-09-01)

Effect of surgery on survival of patients with small-cell lung cancer undiagnosed before resection
by: Brice Caput, et al.
Published: (2024-10-01)

Population based study on the progress in survival of primarily metastatic lung cancer patients in Germany
by: Therese Tzschoppe, et al.
Published: (2024-07-01)

Characterization and Separation of Platinum-Based Antineoplastic Drugs by Zwitterionic Hydrophilic Interaction Liquid Chromatography (HILIC)–Tandem Mass Spectrometry, and Its Application in Surface Wipe Sampling
by: Stefano Dugheri, et al.
Published: (2021-05-01)

Exploring Sex-Based Neuropsychological Outcomes in Pediatric Brain Cancer Survivors: A Pilot Study
by: Chiara Colliva, et al.
Published: (2024-11-01)

Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non–small‐cell lung cancer
by: Nicole F. Laslett, et al.
Published: (2018-07-01)

Wait Times and Survival in Lung Cancer Patients across the Province of Quebec, Canada
by: Marie-Hélène Denault, et al.
Published: (2022-04-01)

Investigation of Characteristics and Behavior of Loaded Carboplatin on the, Liposomes Nanoparticles, on the Lung and Ovarian Cancer: An In-Vitro Evaluation
by: Majid Hasanzadegan Roudsari, et al.
Published: (2016-04-01)

The Nine-Year Survival of Patients Operated for Non-Small-Cell Lung Carcinoma in a Tertiary Centre: The Impact of the Tumour Stage and Other Patient-Related Parameters
by: Silviu Vlăsceanu, et al.
Published: (2024-02-01)

Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals <i>CSF3</i> as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet Regimens
by: Pritsana Raungrut, et al.
Published: (2024-12-01)

The Effect of Anemia on Prognostic in Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
by: Ulfah Kartikasari, et al.
Published: (2024-05-01)

Conditional survival analysis of patients with resected non–small cell lung cancerCentral MessagePerspective
by: Talib Chaudhry, MD, et al.
Published: (2023-12-01)

Platinum chemotherapy for early triple-negative breast cancer
by: Sofia RE. Mason, et al.
Published: (2024-06-01)

HOXA9 methylation is not associated with survival in Brazilian patients with lung adenocarcinoma
by: Anna Luiza Silva Almeida Vicente, et al.
Published: (2025-02-01)

Development of a nomogram based on the clinicopathological and CT features to predict the survival of primary pulmonary lymphoepithelial carcinoma patients
by: Kai Nie, et al.
Published: (2024-03-01)